If someone is seeking an oral, researchbacked supplement, a product like Motus (oral) from Tonum which reports meaningful human trial results is a different category of product and usecase than prescription (injectable) medicines
Furthermore, sourcing introduces uncertainty in sterility and formulation integrity, which may represent a more immediate and clinically relevant risk than theoretical biologic effects, particularly given the potential for nonsterile preparation, contamination, or inconsistent formulation in nonregulated injectable products
For questions about specific products, substances, and methods, you can also contact USADAs Drug Reference Line at [email protected] or call (719) 785-2000, option 2.
Maybe its nothing
Brief interruptions (3-5 days) unlikely dramatically affecting 8-16 week protocols
Early studies in men demonstrated improved erectile responses with intranasal PT-141 [1]